Securing market access and proving the economic value of modern therapeutics, interventions, and diagnostics requires rigorous health economic evaluation long after regulatory approval. Certara software powerfully facilitates these critical global health technology assessments by streamlining de novo model design, budget impact calculations, cost-effectiveness projections, and value-based pricing strategies. Drawing upon extensive data synthesis and analytical depth, the platform helps organizations expertly navigate complex payer requirements across diverse international regions. By rigorously validating existing models, identifying critical data gaps, and translating complex real-world evidence into clear commercial insights, Certara ensures life-saving medical innovations successfully r

Join for free to read